Results 161 to 170 of about 25,406 (311)

Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
The beneficial effects of finerenone in patients with heart failure (HF) and mildly reduced or preserved ejection fraction were consistent, regardless of a history of chronic obstructive pulmonary disease (COPD) status. BMI, body mass index; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.
Jawad H. Butt, Pardeep S. Jhund, Alasdair D. Henderson, Brian L. Claggett, Akshay S. Desai, Carolyn S.P. Lam, Katharina Mueller, Markus F. Scheerer, Prabhakar Viswanathan, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V. McMurray   +16 more
wiley   +1 more source

Intramuscular vasopressin: A feasible intervention for prehospital hemodynamic stabilization in porcine hemorrhagic shock and whole blood transfusion. [PDF]

Transfusion
Renberg M, Karlsson T, Gellerfors M, Gustavsson J, Wellfelt K, Günther M.   +5 more
europepmc   +1 more source

Inactivation of arginine vasopressin by rat-kidney slices [PDF]

, 1961
M. W. Smith, Hans Sachs
openalex   +1 more source

Vasopressin and microalbuminuria: is it vasopressin per se or is it salt intake? [PDF]

Kidney International, 2010
Esther Meijer, Ron T. Gansevoort, Paul E. de Jong   +2 more
openaire   +4 more sources

The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of FINEARTS‐HF

European Journal of Heart Failure, EarlyView.
Effect of finerenone on a hierarchical endpoint. CI, confidence interval; CV, cardiovascular; EF, ejection fraction; HF, heart failure. ABSTRACT Aims FINEARTS‐HF demonstrated the efficacy of finerenone in reducing total worsening heart failure (HF) events (first and recurrent) and cardiovascular death, compared to placebo, in patients with HF and ...
Toru Kondo, Pardeep S. Jhund, Alasdair D. Henderson, Brian L. Claggett, Akshay S. Desai, Meike Brinker, James Lay‐Flurrie, Patrick Schloemer, Prabhakar Viswanathan, Flaviana Amarante, Chern‐En Chiang, Gerasimos Filippatos, Carolyn S.P. Lam, Mark C. Petrie, Michele Senni, Morten Schou, Subodh Verma, Adriaan A. Voors, Dirk von Lewinski, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V McMurray   +23 more
wiley   +1 more source

The effect of vasopressin and hydrocortisone on cytokine trajectories. [PDF]

Intensive Care Med, 2023
Cleasby C, Marshall T, Gordon AC, Antcliffe DB, Sepsis Cytokine Trajectory Investigators.   +4 more
europepmc   +1 more source

Studies on Inhibitory Actions of Synthetic Peptides on the Effects of Oxytocin and Vasopressin

, 1964
Yukio ISHIDA, Kazuko Hara
openalex   +2 more sources

Several Aspects of the Influence of Vasopressin on Pituitary-Adrenal Activity [PDF]

, 1967
D. de Wied, B Bohus, A. M. Ernst, Wybren de Jong, W Nieuwehuizen, Elisabeth E. M. Pieper, Seiichi Yasumura   +6 more
openalex   +1 more source

An Enhanced Metabolization Protocol for In Vitro Genotoxicity Assessment of N‐Nitrosamines in Mammalian Cells

Environmental and Molecular Mutagenesis, EarlyView.
ABSTRACT N‐Nitrosamines (NAs) are probable human carcinogens and were detected as impurities in pharmaceuticals, which led to a concern for human health. NAs require metabolic activation before they become mutagenic, and not all NAs are mutagenic since their reactivity is related to their structure.
M. E. Geijer, A. M. Gernaat, N. Moelijker, I. Brandsma, G. Hendriks   +4 more
wiley   +1 more source

Comparison of different treatments of out-of-hospital cardiac arrest: A systematic review and network meta-analysis. [PDF]

Medicine (Baltimore)
Zhang H, Liu F, Lu X.
europepmc   +1 more source